Iksuda Therapeutics’ £29.6 Million Series A Financing Round

In UK Ashfords LLP, Bird & Bird, advised on the matter.Ashfords LLP advised Iksuda Therapeutics with a team including Vanessa James (Human Capital), Mark Lomas (IP&IT),…

This content is for members only.
Login Join Now

Author: Giulia Di Palma

This content is for members only.
Login Join Now